The End is Near with Adams at Helm

Quote


OK. Mark. Settle down.
 
MG does and so does AK, and that know for a fact. Worked with both before and they admitted that they do. AA is too unconcerned with anything other than increasing his personal wealth, and does not care one iota what the peasants think or say.
 
Anonymous said:
asshole. put your phone number down and ill call you and assure you im not Mark....do you THINK any officer from any company reads this crap?
Click to expand...

Tsk, tsk, tsk...such language, Mark...you should have stayed a sales manager.

Under AA and MG, sales goals stopped being met, Pfizer and GSK have ended strategic alliances, employee turnover is at an all-time high, budgets slashed and there is more bad news to come.

Once enough blood has been spilled, the carcass of AUXL will be sold for far less than anyone ever imagined, imagined, imagined...
 
Anonymous said:
Tsk, tsk, tsk...such language, Mark...you should have stayed a sales manager.

Under AA and MG, sales goals stopped being met, Pfizer and GSK have ended strategic alliances, employee turnover is at an all-time high, budgets slashed and there is more bad news to come.

Once enough blood has been spilled, the carcass of AUXL will be sold for far less than anyone ever imagined, imagined, imagined...
Click to expand...

Hahaha!!! SO TRUE!!!
 
Anonymous said:
http://www.cbsnews.com/8301-505123_162-42841137/sepracor-ceo-got-44-raise-as-he-planned-940-layoffs/

Sepracor CEO Got 44% Raise as He Planned 940 Layoffs
April 08, 2009 by CBSNews.com

Sepracor began the year by announcing the layoffs of about 940 staff -- 530 of its own reps and execs and 410 contract reps. But the pain wasn't felt equally at Sepracor. Top management at the company saw their total compensation rise a combined 20 percent to $23 million.

CEO Adrian Adams saw his pay jump 44 percent from $4.5 million to $6.5 million. Former chairman Timothy Barberich saw his total compensation go up 22 percent from $4.9 million to $6 million.
Click to expand...

Pay attention, people
 
Anonymous said:
http://www.cbsnews.com/8301-505123_162-42841137/sepracor-ceo-got-44-raise-as-he-planned-940-layoffs/

Sepracor CEO Got 44% Raise as He Planned 940 Layoffs
April 08, 2009 by CBSNews.com

Sepracor*began the year by announcing the layoffs of about 940 staff -- 530 of its own reps and execs and 410 contract reps. But the pain wasn't felt equally at Sepracor. Top management at the company saw their total compensation rise a combined 20 percent to $23 million.CEO Adrian Adams*(pictured) saw his pay jump 44 percent from $4.5 million to $6.5 million.*Former chairman Timothy Barberich*saw his total compensation go up 22 percent from $4.9 million to $6 million.
Click to expand...

SLEAZY
 
Anonymous said:
Keep letting rams do nothing and product will sit. They should be ensuring IVs are pulled through. Waste of a position.
Click to expand...

Product is going to sit regardless. RAMs should go, not because they're not doing anything; but, because there is nothing for them to do. Consider the number of RAMs there are, versus the number of IVs being submitted per region. Too many RAMs! Other, more successful, companies operate with a third of the support.

This drug was doomed before it even launched. First, it was priced too high. Second, the territory goals were not properly established. Third, executive management grossly underestimated the specialty's experience with injectible Buy & Bill drugs. And, last.....they overestimated how readily physicians would be willing to abandon the very thing for which they went to medical school - surgery, for the chance to use XIAFLEX.

Don't get me wrong.....XIAFLEX is a good product. It does exactly what it is marketed to do. But, how you start off, will have a lot to do with how you finish.

HUBRIS KILLS!!!!!!!
 
Anonymous said:
Product is going to sit regardless. RAMs should go, not because they're not doing anything; but, because there is nothing for them to do. Consider the number of RAMs there are, versus the number of IVs being submitted per region. Too many RAMs! Other, more successful, companies operate with a third of the support.

This drug was doomed before it even launched. First, it was priced too high. Second, the territory goals were not properly established. Third, executive management grossly underestimated the specialty's experience with injectible Buy & Bill drugs. And, last.....they overestimated how readily physicians would be willing to abandon the very thing for which they went to medical school - surgery, for the chance to use XIAFLEX.

Don't get me wrong.....XIAFLEX is a good product. It does exactly what it is marketed to do. But, how you start off, will have a lot to do with how you finish.

HUBRIS KILLS!!!!!!!
Click to expand...

You're right. I miss you. Hope things are well.
 
Re: The End is Near with Adams at Helw

Anonymous said:
Tsk, tsk, tsk...such language, Mark...you should have stayed a sales manager.

Under AA and MG, sales goals stopped being met, Pfizer and GSK have ended strategic alliances, employee turnover is at an all-time high, budgets slashed and there is more bad news to come.

Once enough blood has been spilled, the carcass of AUXL will be sold for far less than anyone ever imagined, imagined, imagined...
Click to expand...

Seems like it
 


Write your reply...
Top Bottom
Back
Quote